Autoantiidiotypic antibodies in myasthenia gravis.
D000328:Adult; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology*; D001327:Autoimmune Diseases / Q000276:immunology*; D005260:Female; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007074:Immunoglobulin G / Q000627:therapeutic use; D007130:Immunoglobulin Idiotypes / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007231:Infant, Newborn; D007963:Leukocytes, Mononuclear / Q000276:immunology; D008954:Models, Biological; D009157:Myasthenia Gravis / Q000151:congenital / Q000276:immunology* / Q000628:therapy; D010951:Plasma Exchange; D011247:Pregnancy; D011248:Pregnancy Complications / Q000276:immunology; D011978:Receptors, Nicotinic / Q000276:immunology*; D013934:Thymectomy
D000888:Antibodies, Anti-Idiotypic; D001323:Autoantibodies; D007074:Immunoglobulin G; D007130:Immunoglobulin Idiotypes; D007166:Immunosuppressive Agents; D011978:Receptors, Nicotinic